Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Coagulation Factors and Postpartum Hemorrhage

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02604602
Recruitment Status : Active, not recruiting
First Posted : November 13, 2015
Last Update Posted : July 25, 2018
Sponsor:
Information provided by (Responsible Party):
University of Zurich

Brief Summary:
Objective is to analyze a possible association of coagulation factors peripartal with the occurrence of postpartum hemorrhage.

Condition or disease Intervention/treatment
Postpartum Hemorrhage Other: blood exam

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 1500 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 2 Weeks
Official Title: Peripartal Concentration of Coagulation Factors and Postpartum Hemorrhage
Study Start Date : October 2015
Estimated Primary Completion Date : November 2018
Estimated Study Completion Date : December 2018

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
PPH Other: blood exam
laboratory test

non-PPH Other: blood exam
laboratory test




Primary Outcome Measures :
  1. occurrence of PPH [ Time Frame: 7 days ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
pregnant women before delivery
Criteria

Inclusion Criteria:

  • pregnant women > 22 weeks of gestation

Exclusion Criteria:

  • age < 18 years, no informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02604602


Locations
Layout table for location information
Switzerland
University Hospital of Zurich
Zurich, Switzerland, 8091
Sponsors and Collaborators
University of Zurich
Investigators
Layout table for investigator information
Principal Investigator: Christian Haslinger, M.D. Division of Obstetrics, University Hospital of Zurich

Additional Information:

Layout table for additonal information
Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT02604602     History of Changes
Other Study ID Numbers: KEK-ZH-Nr. 2015-0011
First Posted: November 13, 2015    Key Record Dates
Last Update Posted: July 25, 2018
Last Verified: July 2018

Keywords provided by University of Zurich:
PPH

Additional relevant MeSH terms:
Layout table for MeSH terms
Postpartum Hemorrhage
Hemorrhage
Pathologic Processes
Obstetric Labor Complications
Pregnancy Complications
Puerperal Disorders
Uterine Hemorrhage